EDIT vs HUBB · rev $32.3M vs P/E 28, rev $5.63B
Editas Medicine Inc (EDIT) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported HUBB revenue for 2024-12-31 was $5.63B. Net income was $783.5M. Revenue was up 4.8% from 2023-12-31 to 2024-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
EDIT currently screens at market cap $375.2M. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the EDIT and HUBB stock pages for the full models.
Not investment advice.